product Name：Oxatomide
  • Oxatomide [USAN:INN:BAN:JAN]; 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one; 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone; 2H-Benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-; BRN 4724760; KW-4354; McN-JR 35443; Oxatimide; Oxatomida; Oxatomida [INN-Spanish]; Oxatomidum; Oxatomidum [INN-Latin]; Oxetal; R 35443; Tinset; UNII-J31IL9Z2EE; 2H-Benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-; 1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-1,3-dihydro-2H-benzimidazol-2-one
  • 60607-34-3
  • 262-320-9
  • C27H30N4O
  • 426.5533
  • InChI=1/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)
  • Oxatomide 60607-34-3
  • 1.175g/cm3
  • 621.1°C at 760 mmHg
  • 1.619
  • 329.4°C
  • 5.1E-16mmHg at 25°C
  •  Xn:Harmful;
  • R22:;